Embodiments or arrangements disclosed herein relate to methods and apparatuses for dressing and treating a wound with topical negative pressure (TNP) therapy. For example but without limitation, some embodiments disclosed herein relate to treating a wound with reduced pressure provided from a pump. As another non-limiting example, some embodiments disclosed herein relate to apparatuses and methods for controlling the operation of a TNP system.
A number of techniques have been developed for treatment of wounds, including wounds resulting from accident and wounds resulting from surgery. Often, wounds are closed using sutures or staples. However, inserting these mechanical closure techniques requires making additional punctures or wounds to the skin, which can result in tissue injury and in the case of excess swelling, possible ischemia and tissue loss. Also, mechanical wound closures such as staples and sutures can cause highly-localized stresses at the insertion points that can impede and damage the normal wound healing processes of the skin.
In recent years, there has been increased interest in using negative pressure devices for the treatment of wounds. Negative pressure wound treatment utilizes devices that remove wound fluids by applying negative pressure suction to the wound. It is believed that such negative pressures promote wound healing by facilitating the formation of granulation tissue at the wound site and assisting the body's normal inflammatory process while simultaneously removing excess fluid, which may contain adverse cytokines bacteria. However, further improvements in negative pressure wound therapy are needed to fully realize the benefits of treatment.
Many different types of wound dressings are known for aiding in the healing process of a human or animal. These different types of wound dressings include many different types of materials and layers, for example, gauze, pads, foam pads or multi-layer wound dressings. Topical negative pressure (“TNP”) therapy, sometimes referred to as vacuum assisted closure, negative pressure wound therapy, or reduced pressure wound therapy, is widely recognized as a beneficial mechanism for improving the healing rate of a wound. Such therapy is applicable to a broad range of wounds such as incisional wounds, open wounds and abdominal wounds or the like.
TNP therapy assists in the closure and healing of wounds by reducing tissue oedema; encouraging blood flow; stimulating the formation of granulation tissue; removing excess exudates and may reduce bacterial load and thus, infection to the wound. Furthermore, TNP therapy permits less outside disturbance of the wound and promotes more rapid healing.
Surgeons have described open wounds that are difficult to close such as open abdominal wounds after surgery and fasciotomy wounds. These wounds cannot always be closed and can require skin grafts to aid the closure. In some cases, the dressing itself may hinder the closure of the wound by creating a stiffened layer of material over the wound that is resistant to contraction.
Embodiments of the present disclosure relate to wound dressings configured to provide a sealed cover over a wound, providing a sealed space over the wound suitable for maintaining a desired level of reduced pressure within the sealed space over the wound.
Some embodiments are directed to a wound dressing for use in the application of negative pressure to a wound of a patient's body, comprising a support member having a plurality of legs (also referred to herein as arms or body portions) and a top portion (also referred to herein as a top portion), the legs projecting from the top portion and being positionable adjacent a periphery of the wound, and a cover member positionable over the support member. Each leg can be configured to be rotabable relative to an axis axially through the top portion so that a rotational position of each leg of the support member can be adjusted and such that the width of the support member can be adjusted.
Some embodiments comprise a wound dressing for use in the application of negative pressure to a wound of a patient's body, comprising a support member having a first side support and a second side support coupled with a top portion, and a cover member positionable over the support member. In some embodiments, the first side support can be rotatable about the top portion, the second side support can be rotatable about the top portion, and the first side support can be rotatable relative to the second side support so that a rotational position of the first side support and the second side support can be adjusted and such that the width of the support member can be adjusted.
Some embodiments are directed to a method of treating a wound, comprising positioning a support member having a first side support and a second side support both rotatably coupled to a top portion at a location adjacent the wound such that the first side support and the second side support are positioned adjacent the periphery of the wound, positioning a wound cover over the wound, sealing the wound cover to the skin surrounding the wound so that a substantially fluid-tight space is created over the wound, and applying negative pressure to the space over the wound through a conduit in fluid communication with the space over the wound. In some embodiments, the application of negative pressure can cause the first side support and the second side support to rotate relative to an axis through the top portion to decrease a width of the support member and draw edges of the wound closer together.
Some embodiments comprise a support structure for placement in a wound, comprising an elongate top portion extending along a longitudinal axis, and a plurality of side supports connected to the elongate top portion and rotatable about the longitudinal axis, wherein at least one of the side supports is configured to be positioned adjacent one side of a wound and at least another of the side supports is configured to be positioned adjacent another side of the wound.
Any of the features, components, or details of any of the arrangements or embodiments disclosed in this application, including those disclosed below, are interchangeably combinable with any other features, components, or details of any of the arrangements or embodiments disclosed herein to form new arrangements and embodiments. With that, the following arrangements are disclosed herein, inter alia.
1. A wound dressing for use in the application of negative pressure to a wound, comprising:
a support member comprising:
a cover member positionable over the wound in use;
wherein:
2. The wound dressing of arrangement 1, wherein the support member is configured such that, in use, the body portion of the first support element is adjustable so as to extend in a first direction away from the first axis and the body portion of the second support element is adjustable so as to extend in a second direction away from the first axis, the second direction being different than the first direction such that an angle is defined between the body portion of the first support element and the body portion of the second support element.
3. The wound dressing of arrangement 2, wherein the angle between the body portion of the first support element and the body portion of the second support element is from approximately 50 degrees to approximately 90 degrees, or from approximately 50 degrees to approximately 70 degrees, before reduced pressure has been supplied to the space between the cover member and the wound and wherein the angle between the body portion of the first support element and the body portion of the second support element is from approximately 0 degrees to approximately 40 degrees, or from approximately 0 degrees to approximately 20 degrees, or from approximately 10 degrees to approximately 20 degrees, after reduced pressure has been supplied to the space between the cover member and the wound.
4. The wound dressing of any one of the previous arrangements, wherein:
5. The wound dressing of any one of arrangements 2-3, wherein the wound dressing is configured such that, when reduced pressure is supplied to the space between the cover member and the wound, the body portion of the first support element is configured to rotate about the first axis toward the body portion of the second support element so as to reduce the angle between body portion of the first support element and the body portion of the second support element.
6. The wound dressing of any one of the previous arrangements, wherein the cover member is configured to adhere to a skin surface surrounding the wound and to provide a substantially gas-tight sealed space over the wound, and wherein the cover member does not have adhesive in a middle portion of the cover member.
7. The wound dressing of any one of the previous arrangements, wherein the support member further comprises a shaft member coaxial with the first axis, and wherein the first support element and the second support element are configured to rotate about the shaft member.
8. The wound dressing of any one of the previous arrangements, wherein the first portion of at least one of the first support element and the second support element defines a cylindrical shape and has an opening axially therethrough, the opening being coaxial with the first axis.
9. The wound dressing of any one of the previous arrangements, wherein a length of the body portion of the first support element is adjustable in the first direction relative to the first axis and/or a length of the body portion of the second support element is adjustable in the second direction relative to the first axis.
10. The wound dressing of any one of the previous arrangements, wherein the cover member is positioned between the support member and the wound in use.
11. The wound dressing of any one of the previous arrangements, wherein the cover member is positioned between the support member and the wound in use, the cover member being tethered to the support member so that the support member maintains the cover member out of contact with the wound.
12. The wound dressing of any one of the previous arrangements, wherein the cover member is configured to be positioned over the support member in use.
13. The wound dressing of any one of the previous arrangements, further comprising:
14. The wound dressing of any one of the previous arrangements, further comprising a conduit in fluid communication with the space between the cover member and the wound, the conduit being configured to provide reduced pressure to said space.
15. The wound dressing of any one of the previous arrangements, further comprising a wound filler positionable between the cover member and the wound in use.
16. The wound dressing of any one of the previous arrangements, comprising a wound filler positionable between the cover member and the wound in use, the filler comprising at least one of foam, gauze, a deflatable hollow member, a sealed enclosure, a sealed enclosure having a collapsible structure therein, and any combination of the foregoing.
17. The wound dressing of any one of the previous arrangements, comprising a collapsible wound filler positionable between the cover member and the wound in use, the collapsible wound filler comprising at least one of foam, gauze, a deflatable hollow member, a sealed enclosure, a sealed enclosure having a collapsible structure therein, and any combination of the foregoing.
18. The wound dressing of any one of the previous arrangements, comprising a collapsible wound filler positionable between the cover member and the wound in use, the collapsible wound filler comprising at least one of foam, gauze, a deflatable hollow member, a sealed enclosure, a sealed enclosure having a collapsible structure therein, and any combination of the foregoing, wherein the collapsible wound filler is configured to be more flexible and, hence, more collapsible, in a lateral direction than in a vertical direction.
19. The wound dressing of any one of the previous arrangements, comprising a collapsible wound filler positionable between the cover member and the wound in use, wherein the wound filler is configured to support an end portion of the body portion of the first support element and an end portion of the body portion of the second support element in use.
20. The wound dressing of any one of the previous arrangements, comprising from 4 to 8 first support elements and from 4 to 8 second support elements.
21. The wound dressing of any one of the previous arrangements, wherein at least one of the first support element and the second support element is wider in a direction parallel to the first axis than it is longer in a direction away from the first axis.
22. The wound dressing of any one of the previous arrangements, comprising:
23. The wound dressing of any one of the previous arrangements, comprising a pad positioned at an end portion of the body portion of at least one of the first and the second support elements.
24. A wound dressing kit, comprising the wound dressing of any one of the preceding arrangements and a vacuum pump.
25. A wound dressing kit, comprising the wound dressing of any one of the preceding arrangements, a vacuum pump, and a collection canister for collection of wound exudate removed from the wound.
26. A wound dressing for use in the application of negative pressure to a wound of a patient's body, comprising:
27. The wound dressing of arrangement 26, wherein portions of the body portion can be rotated independently.
28. The wound dressing of any one of arrangements 26-27, wherein each portion of the body portion supports at least one leg.
29. The wound dressing of any one of arrangements 26-28, further comprising foam or other wound packing positionable between the wound and the cover member.
30. The wound dressing of any one of arrangements 26-29, wherein one or more of the legs has an adjustable length.
31. The wound dressing of any one of arrangements 26-30, wherein at least a portion of one or more of the legs is extendible to adjust the length thereof.
32. The wound dressing of any one of arrangements 26-31, wherein the cover member is a liquid impermeable drape.
33. The wound dressing of any one of arrangements 26-32, wherein the body portion comprises an elongate member, and further comprising a shaft positioned through an axial centerline of the body portion.
34. The wound dressing of any one of arrangements 26-33, comprising a conduit in communication with a space beneath the cover member, the conduit configured to provide a source of reduced pressure to said space.
35. The wound dressing of any one of arrangements 26-34, comprising one or more cross-supports coupled with two or more legs along one side of the support member.
36. The wound dressing of any one of arrangements 26-35, comprising one or more cross-supports coupled with two or more legs along each side of the support member.
37. The wound dressing of any one of arrangements 26-36, wherein the cover member is positioned mostly outside of the support member.
38. The wound dressing of any one of arrangements 26-37, wherein the cover member is positioned mostly between the support member and the wound.
39. A wound dressing for use in the application of negative pressure to a wound of a patient's body, comprising:
40. The wound dressing of arrangement 39, wherein at least one of the first side support and the second side support comprises two or more legs.
41. The wound dressing of any one of arrangements 39-40, wherein at least one of the first side support and the second side support comprises two or more legs and a cross-support.
42. The wound dressing of any one of arrangements 39-41, wherein at least one of the first side support and the second side support comprises a panel.
43. The wound dressing of any one of arrangements 39-42, wherein portions of the body portion can be rotated independently.
44. The wound dressing of arrangement 43, wherein each portion of the body portion supports at least one leg.
45. The wound dressing of any one of arrangements 39-44, further comprising foam or other wound packing positionable between the wound and the cover member.
46. The wound dressing of any one of arrangements 39-45, comprising one or more legs that has an adjustable length.
47. The wound dressing of any one of arrangements 39-46, comprising one or more legs that is extendible to adjust the length thereof.
48. The wound dressing of any one of arrangements 39-47, wherein the cover member is a liquid impermeable drape.
49. The wound dressing of any one of arrangements 39-48, wherein the body portion comprises an elongate member, and further comprising a shaft positioned through an axial centerline of the body portion.
50. The wound dressing of any one of arrangements 39-49, comprising a conduit in communication with a space beneath the wound cover, the conduit configured to provide a source of reduced pressure to said space.
51. The wound dressing of any one of arrangements 39-50, comprising one or more cross-supports coupled with two or more legs along one side of the support member.
52. The wound dressing of any one of arrangements 39-51, comprising one or more cross-supports coupled with two or more legs along each side of the support member.
53. The wound dressing of any one of arrangements 39-52, wherein the cover member is positioned mostly outside of the support member.
54. A wound dressing kit, comprising the wound dressing of any one of arrangements 39-53 and a vacuum pump.
55. The wound dressing kit of arrangement 54, further comprising a collection canister for collection of wound exudate.
56. A method of treating a wound, comprising:
57. The method of treating a wound of arrangement 56, comprising positioning the wound cover between the wound and the support member.
58. The method of treating a wound of any one of arrangements 56-57, comprising positioning the wound cover over an outside of the support member.
59. The method of treating a wound of any one of arrangements 56-58, wherein at least one of the first side support and the second side support comprises two or more legs.
60. The method of treating a wound of any one of arrangements 56-59, wherein at least one of the first side support and the second side support comprises two or more legs and a cross-support.
61. The method of treating a wound of any one of arrangements 56-60, wherein at least one of the first side support and the second side support comprises a panel.
62. The method of treating a wound of any one of arrangements 56-61, comprising rotating portions of the body portion independently.
63. The method of treating a wound of any one of arrangements 56-62, comprising positioning foam or other wound packing between the wound and the cover member.
64. The method of treating a wound of any one of arrangements 56-63, comprising first positioning foam adjacent the wound, and then positioning the first and second side supports adjacent edges of the foam.
65. The method of treating a wound of arrangement 64, wherein the first and second side supports are positioned into slits in the foam.
66. The method of treating a wound of any one of arrangements 56-65, comprising adjusting a length of at least one of the first side support and the second side support.
67. The method of treating a wound of any one of arrangements 56-66, wherein the cover member is a liquid impermeable drape.
68. The method of treating a wound of any one of arrangements 56-67, wherein the first and second side supports are rotatable about a shaft positioned through an axial centerline of the body portion.
69. The method of treating a wound of any one of arrangements 56-68, wherein the support member comprises one or more cross-supports coupled with two or more legs along one side of the support member.
70. The method of treating a wound of any one of arrangements 56-69, wherein the support member comprises one or more cross-supports coupled with two or more legs along each side of the support member.
71. The method of treating a wound of any one of arrangements 56-70, wherein the support member comprises one or more cross-supports coupled with two or more legs along each side of the support member.
72. The method of treating a wound of any one of arrangements 56-71, wherein the cover member is positioned mostly outside of the support member.
73. A support structure for placement in a wound, comprising:
74. A wound treatment apparatus, comprising:
75. A support structure for placement in a wound, comprising:
76. A wound treatment apparatus, comprising:
77. A method of treating a wound, the method comprising:
78. A method for promoting would healing, the method comprising:
79. A method as in arrangement 78, further comprising, before placing the frame, placing a piece of foam in the wound.
80. A method, comprising:
81. The method of arrangement 80, further comprising positioning a foam member within the wound.
82. The method of any one of arrangements 80-81, further comprising affixing a cover to the collapsible frame to enclose the space defined between the lateral portions.
83. A method of sealing a wound, comprising:
84. The method of arrangement 83, wherein applying a force comprises applying negative pressure.
85. The method of any one of arrangements 83-84, the compression is accomplished through rotation of the legs.
86. A method of treating a wound, comprising:
87. A method of treating a wound, comprising:
88. A method of treating a wound, comprising:
Embodiments of the present disclosure will now be described hereinafter, by way of example only, with reference to the accompanying drawings in which:
Embodiments disclosed herein relate to apparatuses and methods of treating a wound with reduced pressure, including pump and wound dressing components and apparatuses. The apparatuses and components comprising the wound overlay and packing materials, if any, are sometimes collectively referred to herein as dressings.
It will be appreciated that throughout this specification reference is made to a wound. It is to be understood that the term wound is to be broadly construed and encompasses open and closed wounds in which skin is torn, cut or punctured or where trauma causes a contusion, or any other superficial or other conditions or imperfections on the skin of a patient or otherwise that benefit from reduced pressure treatment. A wound is thus broadly defined as any damaged region of tissue where fluid may or may not be produced. Examples of such wounds include, but are not limited to, acute wounds, chronic wounds, surgical incisions and other incisions, subacute and dehisced wounds, traumatic wounds, flaps and skin grafts, lacerations, abrasions, contusions, burns, diabetic ulcers, pressure ulcers, stoma, surgical wounds, trauma and venous ulcers or the like. In some embodiments, the components of the TNP system described herein can be particularly suited for incisional wounds that exude a small amount of wound exudate.
As is used herein, reduced or negative pressure levels, such as −X mmHg, represent pressure levels that are below standard atmospheric pressure, which corresponds to 760 mmHg (or 1 atm, 29.93 in Hg, 101.325 kPa, 14.696 psi, etc.). Accordingly, a negative pressure value of −X mmHg reflects absolute pressure that is X mmHg below 760 mmHg or, in other words, an absolute pressure of (760-X) mmHg. In addition, negative pressure that is “less” or “smaller” than X mmHg corresponds to pressure that is closer to atmospheric pressure (e.g., −40 mmHg is less than −60 mmHg). Negative pressure that is “more” or “greater” than −X mmHg corresponds to pressure that is further from atmospheric pressure (e.g., −80 mmHg is more than −60 mmHg).
The negative pressure range for some embodiments of the present disclosure can be approximately −80 mmHg, or between about −20 mmHg and −200 mmHg. Note that these pressures are relative to normal ambient atmospheric pressure. Thus, −200 mmHg would be about 560 mmHg in practical terms. In some embodiments, the pressure range can be between about −40 mmHg and −150 mmHg. Alternatively a pressure range of up to −75 mmHg, up to −80 mmHg or over −80 mmHg can be used. Also in other embodiments a pressure range of below −75 mmHg can be used. Alternatively, a pressure range of over approximately −100 mmHg, or even 150 mmHg, can be supplied by the negative pressure apparatus.
The wound dressing embodiments disclosed herein are configured to aid with the closure of difficult to close wounds. Such embodiments provide support to the dressing or overlay to raise the overlay above the wound surface with a support system that is flexible and is easily contracted in the lateral direction, thereby reducing the lateral “stiffness” that is exerted on the wound by the overlay or dressing. In conventional dressings, the overlay itself, when drawn against the wound under negative pressure, can inhibit the inward movement of the sides of the wound, thereby inhibiting the closure of the wound.
The dressing embodiments disclosed herein can have a support member for positioning at least partially over a wound bed.
With reference to
In some embodiments, the top portion 116 is an elongate member such as, but not limited to, a hollow rod or a hollow shaft. The top portion 116 of the support member 102 can have a plurality of longitudinal members, such as top portions 116a-116h illustrated in
In some embodiments, the support member 102 can have any number of legs 114 appropriate for the size and type of wound to be treated. In the embodiment illustrated in
The legs of the first set of legs can be positioned so as to define a first plane defined by the position of the legs of the first set of legs. The legs of the second set of legs can be positioned so as to define a second plane defined by the position of the legs of the second set of legs. The first and second plane can generally define an A-shape or A-frame, or an upside down V-shaped structure. In some embodiments, though not required to have independent movement, the legs of each group can move in and out of the respective plane due to the independent movement of each leg. Such independent angular adjustability, along with independent lengthwise adjustability in some embodiments as described below, can permit any of the support members herein to accommodate a wide ranging size of wounds and a wide ranging shape of wounds.
In any embodiments disclosed herein, the dressing 100 can be configured such that the first set of legs and the second set of legs of the support member 102 can define an angle therebetween, for example an acute angle, represented by A3 in
In some embodiments, the dressing 100 or any other dressing disclosed herein can be configured such that an angle between the sets of legs 114 of the support member 102 can decrease by 20 degrees (or approximately 20 degrees) or more, or from 15 degrees or less to 50 degrees or more (or approximately 15 degrees or less to approximately 50 degrees or more), or can decrease by up to approximately 120 degrees or more, from a first ambient pressure state (represented by angle A3 in
As shown in
In some embodiments, the drape 106 or any other drape or wound cover disclosed herein can be a flat film type drape. The film in some embodiments can be folded in half and bonded or sealed along the sides thereof to form a triangular tent shape. In some embodiments, the drape can be custom molded into the desired shape, which can be a triangular tent shape. In some embodiments the tent-drape may be fabricated from plastic film panels and heat welded together. Suitable materials include films made from polyurethane, Opsite film, polyester, polyethylene etc. Some drapes may be translucent in nature to allow visibility of the interior of the dressing. In some embodiments, the tent-drape will have no adhesive. Alternatively the tent may have an adhesive strip covered with a removable protector for adhering it to the wound periphery. Alternatively the tent is sealed to the patient using adhesive drapes or tape, e.g. Opsite or a RENASYS transparent film dressing.
As shown in
In some embodiments, a foam member 112 or other wound packing member can be positioned in the wound bed. The support member 102 can collapse or close laterally around the wound packing material or foam (i.e., the sides of the support member 102, which can comprise in some embodiments legs 114, can be drawn together), thereby causing the packing material or foam to be pushed up into the space 126 inside the support member 102, as is illustrated in
In any of the embodiments disclosed herein, the wound packing member can be an inflatable member. Some embodiments of the dressing may have a fluid (for example, without limitation, air) inflatable bladder in addition to any other components of the dressing, including foam, gauze, silicone, and any combination of the foregoing including a matrix formed from silicon and/or foam. One embodiment of an inflatable member may be pumped up before the vacuum is applied. The air or fluid in the inflatable member can then be controllably removed with a pump and/or valve to control the amount of contraction on the wound. This is advantageous for compartment syndrome cases, especially abdominal compartment cases, to relieve pressure on the organs, as too much closure at initial application could recreate this internal pressure on the organs.
Compartment syndrome can occur when excessive pressure builds up inside an enclosed space in the body. Excessive pressures in the abdominal compartment, for example, can impede the flow of blood to and from the affected tissues, bodily organs, or even the lower extremities if excessive pressure is exerted on the abdominal aorta. The pressure buildup within the abdominal compartment can be the result of excessive fluid buildup in the abdominal compartment, in addition to or alternatively as a result of the forces exerted on the abdominal region from the application of negative pressure wound therapy to the abdominal compartment.
Such excessive pressure can cause permanent injury or damage to the tissues, organs (such as the liver, bowels, kidneys, and other organs), and other body parts affected by the reduction of blood flow. Therefore, preventing the buildup of excessive pressures in the abdominal compartment is beneficial for the treatment of abdominal injuries.
Internal pressure may also be measured and/or monitored via the gastrointestinal system (including colonically), or via the uterus. In some arrangements, for example, the internal pressure may be measured by inserting a catheter into the patient's bladder. Aortic blood pressure can also be monitored using techniques known in the field. For limb-based compartment syndrome, the internal pressure can be measured by a needle inserted into the affected limb, and preferably, the pressure measured there should be within 20-30 mmHg of the patient's diastolic blood pressure. The clinician may also monitor for a pulse distal of the affected extremity.
In addition to any of the foregoing methods or devices for measuring internal pressure, or any combination of such, in some embodiments, any of the negative pressure wound therapy dressing components disclosed herein can be configured to support or contain one or more pressure sensors configured to permit a clinician to monitor the internal pressure within the compartment, wound cavity, or abdominal cavity. For example, one or more pressure sensors can be added to the dressing components, including without limitation positioning one or more pressure sensors on the surface of and/or inside any inflatable bladder embodiment disclosed herein that can be positioned in the abdominal cavity. The pressure sensors can be supported on, embedded within, or be integral with an outer and/or inner surface of any inflatable bladder embodiments disclosed herein, and can be used to monitor the pressure exerted on the inflatable bladder from the adjacent tissues and organs within the abdominal cavity to alert the patient or caregiver when a threshold or potentially harmful pressure is present within the abdominal cavity.
Additionally or alternatively, one or more pressure sensors can be positioned on or supported by a portion of any wound packing or silicone matrix components positioned within or adjacent to the wound cavity, or embedded within a portion of the matrix and/or the dressing overlay or cover, including being supported by the overlay itself, and/or any conduit components of the dressing. The pressure sensors can therefore be positioned on, supported by, or embedded within any combination of the dressing components disclosed herein.
Furthermore, in addition or alternatively to any of the sensor positions located herein, one or more pressure sensors can also be positioned adjacent to one or more of the organs in the cavity being treated, for example the bladder, one or more kidneys, and/or any other organs or proximally located tissue surfaces. Some embodiments can have one or more pressure sensors supported by or on or embedded within the wound packing layer or matrix, one or more pressure sensors supported by or on or embedded within one or more of the organs or tissue layers in the cavity, and one or more pressure sensors supported by or on or embedded within one or more inflatable bladders positioned within the wound cavity.
Monitoring the pressure in each of these three locations can permit the caregiver to optimize or control the level of negative pressure applied to the wound cavity, optimize or control a level of inflation or pressure of the inflatable bladder, and/or monitor a level of pressure exerted on one or more organs, tissue layers, blood vessels, or other body parts affected by the closure pressures. A caregiver can then adjust a level of pressure in the inflatable bladder by either adding fluid to the bladder or releasing fluid from within the bladder to a receptacle or container positioned outside the body, adjust a level of negative pressure exerted on the wound cavity, and/or adjust any other closure forces applied to the wound to either increase or decrease the closure forces.
A clinician may monitor the internal pressure as vacuum is slowly increased to the wound dressing, or as air is slowly released from the inflatable member. In one embodiment, bladder pressure is controlled below 40 mm Hg. In some embodiments, the measurement of internal pressure and control of the vacuum and air release can be controlled automatically. This way as the oedema decreases the wound can be slowly closed further over, for example, a period of hours to days (e.g., closure by seven days). It will be appreciated that systems can be employed where the vacuum can be slowly applied with pressure feedback being provided based on vital signs of the patient.
In some embodiments the legs 814 are positioned inside the wound edges so that the legs penetrate to almost the bottom of the wound. Some embodiments and methods can have the legs 814 completely to the bottom of the wound so as to be adjacent to or in contact with all of the tissue layers in the wound interface. This may be accomplished in one embodiment by providing slits in the foam.
The size of each component or feature of each support member can be adjusted based on the size of the wound being treated and other details of the application. With reference to
In some embodiments, the legs 114 can have a circular cross-section such that the width W1 and the thickness T1 will be diameters and will be approximately the same. However, the legs 114 or any other legs disclosed herein can have any suitable cross-sectional shape, including round, square, triangular, rectangular, hexagonal, hollow, solid, or otherwise. In some embodiments, where the top portion 116 can have a circular cross-section, the height H1 will be a diameter. However, the top portion 116 or any other top portion disclosed herein can have any suitable cross-sectional shape, including round, square, triangular, rectangular, hexagonal, or otherwise. The lateral width Wsm of the support member 102 can be approximately 7 inches, or from approximately 3 inches or less to approximately 12 inches or more. The thickness or width W4 of the top portion 116 can be approximately 0.19 inch, or from approximately 0.1 inch or less to approximately 0.3 inch or more. Where the top portion 116 or any other top portion disclosed herein has a round cross-sectional shape, as in the embodiment illustrated in
Additionally, the arms 114 can be spaced apart from one another at any desired length or interval. For example, without limitation, the spacing S1 (illustrated in
Additionally, with reference to
It is also envisaged, for example in embodiments such to those illustrated in
The panels 514 can be approximately 6 inches wide, or can be from 1 inch to 5 inches wide, or from 5 to 10 inches wide (or from approximately 1 inch wide to approximately 4 inches wide, or from approximately 4 inches wide or less to approximately 10 inches wide) or more. The top portions 516 can be approximately 1.2 inches wide, or from 0.5 inch wide to 2 inches wide (or approximately 0.5 inch wide or less to approximately 2 inches wide) or more. Narrower panels or narrow top portions can permit greater articulation or flexibility in the support member.
In any of the embodiments disclosed herein, the drape or wound cover can be positioned on the outside of the support member, as illustrated in
The minimal closure observed with negative wound pressure applied using the standard abdominal kit can be seen in
In
Any embodiments of the dressing 900 and the support member 902 can have any of the features, materials, sizes, shapes, components, or other details of any of the other embodiments disclosed herein, such as without limitation the dressing 100 and support member 102. Additionally, the dressing 900 can have one or more differences as compared to the other dressings disclosed herein. For example, one or more of the arms 914 can have lower section 914a that is formed at a different angle than an upper section 914b of the arms. In some embodiments, the lower portion 914a of each arm can be angled inwardly. Though not required, the lower portion 914a of each arm can be angled such that, when the arms 914 are rotated away from one another, the lower portion 914a of each arm 914 will be approximately perpendicular to the skin or wound surface beneath the lower portion 914a of the arm 914. Additionally, the arms 914 can be staggered from one another along the length of the support member 902 so as to be interdigitated or positioned between the arms 914 positioned on an opposite side of the support member 902. In this arrangement, the arms 914 positioned on one side of the support member 902 will not interfere with the arms 914 positioned on an opposite side of the support member 902 when the sides of the support member 902 are drawn together.
As illustrated, any embodiments of the dressing 900 can have a wound filler 912 positionable beneath a cover member in the wound. In any embodiments disclosed herein, including without limitation the embodiment illustrated in
As with any of the wound embodiments disclosed herein, the arms 1014 of the support member 1002 can support the cover member or dressing 1006 above the wound bed, and can span from one end of the wound to another opposite end of the wound, or can bridge the wound entirely. In some embodiments, the arms 1014 can be arc shaped, triangular shaped, or otherwise. A flat bottom portion 1005 of the support member 1002 can be positioned along the length of the wound and the sides of the drape 1006 can be pulled apart and down against the surface of the skin adjacent to the wound on opposite sides of the wound, thereby expanding the arms 1014 of the support member 1002 apart (opening the arms 1014 in a fan type effect or manner), as shown in
Any embodiments of the dressing 1000 can have a wound filler positionable beneath a cover member in the wound. In any embodiments disclosed herein, including without limitation the embodiment illustrated in
The arms 1114 of the support member 1102 can support a cover member or dressing 1106 (not illustrated) above the wound bed, and can span from one end of the wound to another opposite end of the wound. Some embodiments of the cover can have adhesive along all or a portion of the skin facing surface thereof. Some embodiments of the cover can have adhesive around the perimeter of the cover member, and be adhesive-free in a middle portion of the cover member so that the adhesive does not stick to the support member 1102, which could inhibit the telescoping motion of the support member.
In some embodiments, the arms 1114 can be extendable and contractible, such as in a telescoping fashion. For example, without limitation, the arms 1114 can each have a first or outer arm portion 1113 coupled with or supported by a first side 1102a of the support member 1102, and a second or inner arm portion 1115 coupled with or supported by a second side 1102b of the support member 1102. In some embodiments, the support member 1102 can be configured such that each arm 1114 of the support member 1102 is independently extendable and contractible relative to adjacent arms 1114 or otherwise. In some embodiments, the support member 1102 can be configured such that the arms 1114 of the support member 1102 are not independently extendable and contractible relative to adjacent arms 1114 or otherwise. The arms 1114 can be made from a lubricious material and/or have a lubricant added thereto to enhance the movement of the telescoping sides of the arms 1114 relative to one another.
The support member 1102 can be expanded (as shown in
In some embodiments, though not required, the support member 1102 can be configured such that the arms 1114 are biased toward the collapsed position (i.e., as shown in
Further, though not illustrated, in some embodiments, the arms 1114 of the support member 1102 can be arc shaped to provide buttressing support to the arms and to prevent the arms 1114 from collapsing into the wound bed. The arms can be telescoping in this arc shaped configuration also, or otherwise be configured to be collapsible and extensible in a lateral direction to permit the support member to contract laterally as the reduced pressure applied to the space between the cover member and the wound cavity causes the sides of the wound to contract laterally.
As in any of the embodiments disclosed herein, the dressing can have a drape or cover member configured to cover the wound positioned above or below the support member (including, without limitation, support member 1102). Additionally, in any of the embodiments disclosed herein, the support member 1102 can be embedded or integrated within the cover member. If the cover member is positioned below the support member, the dressing can be configured such that the support member supports the cover member out of contact with the wound surface or filler member, or at least so as to minimize the contact with the wound surface or filler member. Loops, slots (such as the slots in a tent structure), pockets, cords, threads, or other suitable features can be integrated into or added to any of the cover member embodiments disclosed herein to permit the cover member to be supported by the support member and/or to permit the support member to be integrated into the cover member.
Additionally, in any of the dressing embodiments disclosed herein, including without limitation the dressing embodiment 1100 shown in
Additionally, in some embodiments, with reference to
In some embodiments, with reference to
Additionally, the dressing 1400 can have one or more different features, materials, sizes, shapes, components, or other details as compared to the other dressings disclosed herein. For example, one or more of the arms 1414 can have a first arm portion 1415 hingably attached to a second arm portion 1417. In some embodiments, the hinge 1416 can be positioned at approximately the midspan of the arms 1414 and can permit the first and second arm portions 1415, 1417 to rotate relative to one another. Additionally, the first arm portion 1415 can be hingably attached to a first side 1402a of the support member 1402 with a second hinge member 1419 and the second arm portion 1417 can be hingably attached to a second side 1402b of the support member 1402 with a second hinge member 1421.
The arms 1414 of the support member 1402 can support a cover member or dressing 1406 (not illustrated) above the wound bed, and can span from one end of the wound to another opposite end of the wound. In some embodiments, as mentioned, the arms 1414 can have one or more hinges to allow the arms 1114 to collapse, thereby permitting the sides 1402a, 1402b of the support member 1402 (and the sides of the wound) to be drawn together, when the support member 1402 is positioned over a wound and the space between the drape (positioned over or under the support member 1402) is subjected to negative pressure.
The support member 1402 can be expanded (as shown in
In some embodiments, though not required, the support member 1402 can be configured such that the arms 1414 are biased toward the collapsed position (i.e., as shown in
The support members 1514 can provide vertical support or stiffness to the wound filler member 1512 to prevent or inhibit the collapse of the filler member in the vertical direction under the application of reduced pressure, while only minimally inhibiting the lateral contraction of the sides of the wound toward one another (if at all). In other words, the support members 1514 can provide stiffness to the dressing 1500 in a vertical direction (generally perpendicular to the skin surface surrounding the wound) while permitting the wound filler member to be flexible in the lateral direction so that the sides of the wound can contract toward one another (in the direction represented by arrow A1 in
The support members 1514 can therefore provide additional support to prevent the cover member or drape 1506 from collapsing vertically into the wound under the application of reduced pressure. The support members 1514 can extend completely across the filler member 1512 (as illustrated in
Additionally, in some embodiments, the dressing can have one or more rails generally perpendicularly arranged relative to the support members 1514. The one or more rails can provide a slide surface over which the rails can slide in the direction represented by arrows A1 in
Further, though not illustrated, in some embodiments, the support members 1514 can be arc shaped or otherwise shaped to have greater resistance to bending along a length of the support members 1514, to inhibit the support members 1514 from flexing or bending into the wound filler 1512. Additionally or alternatively, the support members 1514 can have a changing profile along a length thereof, wherein the support members have the largest area moment of inertia (such as by increasing the vertical height or profile of the support member or members) in a middle portion of the support members so as to provide the greatest amount of bending resistance in a middle portion of the dressing. Thus, in some embodiments, the support members 1514 can have an arc shaped or curved shape in addition to having an increased area moment of inertia in a middle portion of the support members.
The support members 1614 can provide vertical support or stiffness to the dressing 1600 to prevent or inhibit the collapse of the filler member 1612 or the drape 1606 in the vertical direction under the application of reduced pressure, while only minimally inhibiting the lateral contraction of the sides of the wound toward one another (if at all). In other words, the support members 1614 can provide stiffness to the dressing 1600 in a vertical direction (generally perpendicular to the skin surface surrounding the wound) while permitting the wound filler member to be flexible in the lateral direction so that the sides of the wound can contract toward one another (in the direction represented by arrows A1 in
The support members 1614 can therefore provide additional support to prevent the cover member or drape 1606 from collapsing vertically into the wound under the application of reduced pressure. The support members 1614 can extend completely across the wound or partially across the wound and are positionable over the filler member 1612 and/or over the cover member after the filler member and/or cover member have been positioned in or over the wound. Additionally, in some embodiments, the support members 1614 can be integrated or embedded into, or otherwise attached to, the cover member 1606 prior to placement of the cover member over the wound. For example, in some embodiments, the cover member 1606 can be attached to or supported by the support member using sutures, straps, loops, tape, or any other securing mechanisms 1620 attached to the cover member 1606 and the support member 1602. In any embodiments disclosed herein, the wound filler can comprise at least one of foam, gauze, a deflatable hollow member, a sealed enclosure, a sealed enclosure having a collapsible structure therein, and any combination of the foregoing.
Additionally, in some embodiments, the dressing can have one or more rail members 1616 (also referred to herein as girder or beam members) generally perpendicularly arranged relative to the support members 1614. The one or more rail members 1616 can provide support to the support members to elevate the support members above the skin surface. The support members 1614 can slide in the direction represented by arrows A1 in
Further, in some embodiments, either or both of the support members 1614 or rail members 1616 can be arc shaped or otherwise shaped to have greater resistance to bending along a length of either or both of the support members 1614 or rail members 1616, to inhibit the support members 1614 and/or rail members 1616 from flexing or bending into the wound filler 1612. Additionally or alternatively, either or both of the support members 1614 or rail members 1616 (of which there can be more than two in any embodiments) can have a changing profile along a length thereof, having the largest area moment of inertia (such as by increasing the vertical height or profile of one or more of the support member or members or rail member or members) in a middle portion of the support members and/or rail members so as to provide the greatest amount of bending resistance in a middle portion of the dressing. Thus, in some embodiments, the support members 1614 and/or rail members 1616 can have an arc shaped or curved shape in addition to having an increased area moment of inertia in a middle portion of the support members and/or rail members. The support members 1614 can be configured to slide laterally relative to the rail members 1616 to allow the support members to slide as the walls of the wound contract.
The support members and rail members in each dressing kit or embodiment can have a variety of lengths, depending on the shape of the wound, position of the support member, shape and profile of the wound filler, etc. Additionally, the number and position of the support members can vary. In some embodiments, there can be from 3 to 10 support members positioned over a wound, in any of a variety of positions and having a variety of lengths and shapes.
Some embodiments of the cover can have adhesive along all or a portion of the skin facing surface thereof. Some embodiments of the cover can have adhesive around the perimeter of the cover member, and be adhesive-free in a middle portion of the cover member so that the adhesive does not stick to the support members 1614. Additionally, in some embodiments, the support members 1614 and/or rail members 1616 can be positioned, embedded, or integrated within or attached or adhered to the cover member 1606. Further, as with any of the dressing embodiments disclosed herein, the support members 1614 can be configured to be positioned over and above at least a portion of the cover member such that the cover member is attached or tethered to the support members 1614. If the cover member is positioned below the support member, the dressing can be configured such that the support member supports the cover member out of contact with the wound surface or filler member, or at least so as to minimize the contact with the wound surface or filler member. Loops, slots (such as the slots in a tent structure), pockets, cords, threads, or other suitable features can be integrated into or added to any of the cover member embodiments disclosed herein to permit the cover member to be supported by the support member and/or to permit the support member to be integrated into the cover member.
In any embodiments disclosed herein, the support member can have one or more tissue anchors, fixation mesh, tissue connectors, and/or other tissue engaging elements configured to engage one or more of the tissue layers adjacent to the legs of the support member. For example, in some embodiments, a plurality of tissue anchors can be supported by the legs, panels, the inflatable bladder or filler positioned in the wound, or any other component or feature of the support member or dressing member disclosed herein.
In some embodiments, one or more tissue anchors, mesh, or other tissue engaging elements can be tethered to the legs, panels, the inflatable bladder or filler positioned in the wound, or any other component or feature of the support member or dressing member disclosed herein. The tissue anchors can be tethered to the legs, panels, the inflatable bladder or filler positioned in the wound, or any other component or feature of the support member or dressing member disclosed herein using sutures, clips, strands, tape, or other tethering mechanisms.
Examples of attachment mechanisms for engaging tissue include adhesive, grippers or barbs, Velcro, hooks of Velcro, mushroom shaped hooks of Velcro, or other attachment mechanism known in the art.
Features, materials, characteristics, or groups described in conjunction with a particular aspect, embodiment, or example are to be understood to be applicable to any other aspect, embodiment or example described herein unless incompatible therewith. All of the features disclosed in this specification (including any accompanying claims, abstract and drawings), and/or all of the steps of any method or process so disclosed, may be combined in any combination, except combinations where at least some of such features and/or steps are mutually exclusive. The protection is not restricted to the details of any foregoing embodiments. The protection extends to any novel one, or any novel combination, of the features disclosed in this specification (including any accompanying claims, abstract and drawings), or to any novel one, or any novel combination, of the steps of any method or process so disclosed.
While certain embodiments have been described, these embodiments have been presented by way of example only, and are not intended to limit the scope of protection. Indeed, the novel methods and systems described herein may be embodied in a variety of other forms. Furthermore, various omissions, substitutions and changes in the form of the methods and systems described herein may be made. Those skilled in the art will appreciate that in some embodiments, the actual steps taken in the processes illustrated and/or disclosed may differ from those shown in the figures. Depending on the embodiment, certain of the steps described above may be removed, others may be added. Furthermore, the features and attributes of the specific embodiments disclosed above may be combined in different ways to form additional embodiments, all of which fall within the scope of the present disclosure.
Although the present disclosure includes certain embodiments, examples and applications, it will be understood by those skilled in the art that the present disclosure extends beyond the specifically disclosed embodiments to other alternative embodiments and/or uses and obvious modifications and equivalents thereof, including embodiments which do not provide all of the features and advantages set forth herein. Accordingly, the scope of the present disclosure is not intended to be limited by the specific disclosures of preferred embodiments herein, and may be defined by claims as presented herein or as presented in the future.
This application is a continuation application of U.S. patent application Ser. No. 15/837,948, filed Dec. 11, 2017, which is a continuation application of U.S. patent application Ser. No. 14/402,674, filed Nov. 20, 2014, which is a National Phase Application of PCT Patent Application PCT/IB2013/002485, filed on May 21, 2013, which claims the benefit of U.S. Provisional Application Nos. 61/650,391, filed May 22, 2012, 61/681,037, filed Aug. 8, 2012, 61/784,304, filed Mar. 14, 2013, and 61/651,483, filed May 24, 2012, the contents of which are hereby incorporated by reference in their entireties as if fully set forth herein. The benefit of priority to the foregoing applications is claimed under the appropriate legal basis including, without limitation, under 35 U.S.C. § 119(e).
Number | Name | Date | Kind |
---|---|---|---|
3014483 | Frank et al. | Dec 1961 | A |
3194239 | Sullivan et al. | Jul 1965 | A |
3578003 | Everett | May 1971 | A |
3789851 | Leveen | Feb 1974 | A |
3812616 | Koziol | May 1974 | A |
4467805 | Fukuda | Aug 1984 | A |
4608041 | Nielsen | Aug 1986 | A |
4637819 | Ouellette et al. | Jan 1987 | A |
4699134 | Samuelsen | Oct 1987 | A |
4815468 | Annand | Mar 1989 | A |
5176663 | Svedman et al. | Jan 1993 | A |
5264218 | Rogozinski | Nov 1993 | A |
5368910 | Langdon | Nov 1994 | A |
5376067 | Daneshvar | Dec 1994 | A |
5409472 | Rawlings et al. | Apr 1995 | A |
5415715 | Delage et al. | May 1995 | A |
5423857 | Rosenman et al. | Jun 1995 | A |
5512041 | Bogart | Apr 1996 | A |
5514105 | Goodman, Jr. et al. | May 1996 | A |
5562107 | Lavender et al. | Oct 1996 | A |
5584859 | Brotz | Dec 1996 | A |
5636643 | Argenta et al. | Jun 1997 | A |
5695777 | Donovan et al. | Dec 1997 | A |
5928210 | Ouellette et al. | Jul 1999 | A |
5960497 | Castellino et al. | Oct 1999 | A |
6080168 | Levin et al. | Jun 2000 | A |
6086591 | Bojarski | Jul 2000 | A |
6142982 | Hunt et al. | Nov 2000 | A |
6176868 | Detour | Jan 2001 | B1 |
6291050 | Cree et al. | Sep 2001 | B1 |
6503208 | Skovlund | Jan 2003 | B1 |
6530941 | Muller et al. | Mar 2003 | B1 |
6548727 | Swenson | Apr 2003 | B1 |
6553998 | Heaton et al. | Apr 2003 | B2 |
6566575 | Stickels et al. | May 2003 | B1 |
6685681 | Lockwood et al. | Feb 2004 | B2 |
6695823 | Lina et al. | Feb 2004 | B1 |
6712830 | Esplin | Mar 2004 | B2 |
6712839 | Lonne | Mar 2004 | B1 |
6767334 | Randolph | Jul 2004 | B1 |
6770794 | Fleischmann | Aug 2004 | B2 |
6776769 | Smith | Aug 2004 | B2 |
6787682 | Gilman | Sep 2004 | B2 |
6814079 | Heaton et al. | Nov 2004 | B2 |
6883531 | Perttu | Apr 2005 | B1 |
6893452 | Jacobs | May 2005 | B2 |
6936037 | Bubb et al. | Aug 2005 | B2 |
6951553 | Bubb et al. | Oct 2005 | B2 |
6977323 | Swenson | Dec 2005 | B1 |
6994702 | Johnson | Feb 2006 | B1 |
7004915 | Boynton et al. | Feb 2006 | B2 |
7025755 | Epstein et al. | Apr 2006 | B2 |
7070584 | Johnson et al. | Jul 2006 | B2 |
7117869 | Heaton et al. | Oct 2006 | B2 |
7128735 | Weston | Oct 2006 | B2 |
7144390 | Hannigan et al. | Dec 2006 | B1 |
7153312 | Torrie et al. | Dec 2006 | B1 |
7156862 | Jacobs et al. | Jan 2007 | B2 |
7172615 | Morriss et al. | Feb 2007 | B2 |
7189238 | Lombardo et al. | Mar 2007 | B2 |
7196054 | Drohan et al. | Mar 2007 | B1 |
7198046 | Argenta et al. | Apr 2007 | B1 |
7216651 | Argenta et al. | May 2007 | B2 |
D544092 | Lewis | Jun 2007 | S |
7262174 | Jiang et al. | Aug 2007 | B2 |
7279612 | Heaton et al. | Oct 2007 | B1 |
7315183 | Hinterscher | Jan 2008 | B2 |
7351250 | Zamierowski | Apr 2008 | B2 |
7361184 | Joshi | Apr 2008 | B2 |
7367342 | Butler | May 2008 | B2 |
7381211 | Zamierowski | Jun 2008 | B2 |
7381859 | Hunt et al. | Jun 2008 | B2 |
7413571 | Zamierowski | Aug 2008 | B2 |
7438705 | Karpowicz et al. | Oct 2008 | B2 |
7494482 | Orgill et al. | Feb 2009 | B2 |
7534240 | Johnson | May 2009 | B1 |
7540848 | Hannigan et al. | Jun 2009 | B2 |
7553306 | Hunt et al. | Jun 2009 | B1 |
7553923 | Williams et al. | Jun 2009 | B2 |
7569742 | Haggstrom et al. | Aug 2009 | B2 |
7578532 | Schiebler | Aug 2009 | B2 |
D602583 | Pidgeon et al. | Oct 2009 | S |
7611500 | Lina et al. | Nov 2009 | B1 |
7615036 | Joshi et al. | Nov 2009 | B2 |
7617762 | Ragner | Nov 2009 | B1 |
7618382 | Vogel et al. | Nov 2009 | B2 |
7622629 | Aali | Nov 2009 | B2 |
7625362 | Boehringer et al. | Dec 2009 | B2 |
7645269 | Zamierowski | Jan 2010 | B2 |
7651484 | Heaton et al. | Jan 2010 | B2 |
7670323 | Hunt et al. | Mar 2010 | B2 |
7678102 | Heaton | Mar 2010 | B1 |
7683667 | Kim | Mar 2010 | B2 |
7699823 | Haggstrom et al. | Apr 2010 | B2 |
7699830 | Martin | Apr 2010 | B2 |
7699831 | Bengtson et al. | Apr 2010 | B2 |
7700819 | Ambrosio et al. | Apr 2010 | B2 |
7708724 | Weston | May 2010 | B2 |
7713743 | Villanueva et al. | May 2010 | B2 |
7722528 | Arnal et al. | May 2010 | B2 |
7723560 | Lockwood et al. | May 2010 | B2 |
7754937 | Boehringer et al. | Jul 2010 | B2 |
7776028 | Miller et al. | Aug 2010 | B2 |
7777522 | Yang et al. | Aug 2010 | B2 |
7779625 | Joshi et al. | Aug 2010 | B2 |
D625801 | Pidgeon et al. | Oct 2010 | S |
7815616 | Boehringer et al. | Oct 2010 | B2 |
7820453 | Heylen et al. | Oct 2010 | B2 |
7846141 | Weston | Dec 2010 | B2 |
7857806 | Karpowicz et al. | Dec 2010 | B2 |
7863495 | Aali | Jan 2011 | B2 |
7892181 | Christensen et al. | Feb 2011 | B2 |
7896856 | Petrosenko et al. | Mar 2011 | B2 |
7909805 | Weston | Mar 2011 | B2 |
7910789 | Sinyagin | Mar 2011 | B2 |
7931774 | Hall et al. | Apr 2011 | B2 |
7942866 | Radl et al. | May 2011 | B2 |
7951124 | Boehringer et al. | May 2011 | B2 |
7964766 | Blott et al. | Jun 2011 | B2 |
7976519 | Bubb et al. | Jul 2011 | B2 |
7976524 | Kudo et al. | Jul 2011 | B2 |
7981098 | Boehringer et al. | Jul 2011 | B2 |
8030534 | Radl et al. | Oct 2011 | B2 |
8057447 | Olson et al. | Nov 2011 | B2 |
8062272 | Weston | Nov 2011 | B2 |
8062295 | McDevitt et al. | Nov 2011 | B2 |
8062331 | Zamierowski | Nov 2011 | B2 |
8067662 | Aali et al. | Nov 2011 | B2 |
8070773 | Zamierowski | Dec 2011 | B2 |
8080702 | Blott et al. | Dec 2011 | B2 |
8100887 | Weston et al. | Jan 2012 | B2 |
8114126 | Heaton et al. | Feb 2012 | B2 |
8123781 | Zamierowski | Feb 2012 | B2 |
8128615 | Blott et al. | Mar 2012 | B2 |
8129580 | Wilkes et al. | Mar 2012 | B2 |
8142419 | Heaton et al. | Mar 2012 | B2 |
8162909 | Blott et al. | Apr 2012 | B2 |
8172816 | Kazala, Jr. et al. | May 2012 | B2 |
8182413 | Browning | May 2012 | B2 |
8187237 | Seegert | May 2012 | B2 |
8188331 | Barta et al. | May 2012 | B2 |
8192409 | Hardman et al. | Jun 2012 | B2 |
8197467 | Heaton et al. | Jun 2012 | B2 |
8207392 | Haggstrom et al. | Jun 2012 | B2 |
8235955 | Blott et al. | Aug 2012 | B2 |
8235972 | Adahan | Aug 2012 | B2 |
8246590 | Hu et al. | Aug 2012 | B2 |
8246606 | Stevenson et al. | Aug 2012 | B2 |
8257328 | Augustine et al. | Sep 2012 | B2 |
8273105 | Cohen et al. | Sep 2012 | B2 |
8328776 | Kelch et al. | Dec 2012 | B2 |
8337411 | Nishtala et al. | Dec 2012 | B2 |
8353931 | Stopek et al. | Jan 2013 | B2 |
8357131 | Olson | Jan 2013 | B2 |
8376972 | Fleischmann | Feb 2013 | B2 |
8399730 | Kazala, Jr. et al. | Mar 2013 | B2 |
8430867 | Robinson et al. | Apr 2013 | B2 |
8444392 | Turner et al. | May 2013 | B2 |
8447375 | Shuler | May 2013 | B2 |
8454990 | Canada et al. | Jun 2013 | B2 |
8460257 | Locke et al. | Jun 2013 | B2 |
8481804 | Timothy | Jul 2013 | B2 |
8486032 | Seegert et al. | Jul 2013 | B2 |
8500704 | Boehringer et al. | Aug 2013 | B2 |
8500776 | Ebner | Aug 2013 | B2 |
8523832 | Seegert | Sep 2013 | B2 |
8535296 | Blott et al. | Sep 2013 | B2 |
8608776 | Coward et al. | Dec 2013 | B2 |
8622981 | Hartwell et al. | Jan 2014 | B2 |
8632523 | Eriksson et al. | Jan 2014 | B2 |
8673992 | Eckstein et al. | Mar 2014 | B2 |
8679080 | Kazala, Jr. et al. | Mar 2014 | B2 |
8679153 | Dennis | Mar 2014 | B2 |
8680360 | Greener et al. | Mar 2014 | B2 |
8708984 | Robinson et al. | Apr 2014 | B2 |
8721629 | Hardman et al. | May 2014 | B2 |
8746662 | Poppe | Jun 2014 | B2 |
8747375 | Barta et al. | Jun 2014 | B2 |
8764732 | Hartwell | Jul 2014 | B2 |
8784392 | Vess et al. | Jul 2014 | B2 |
8791315 | Lattimore et al. | Jul 2014 | B2 |
8791316 | Greener | Jul 2014 | B2 |
8801685 | Armstrong et al. | Aug 2014 | B2 |
8802916 | Griffey et al. | Aug 2014 | B2 |
8821535 | Greener | Sep 2014 | B2 |
8843327 | Vernon-Harcourt et al. | Sep 2014 | B2 |
8945030 | Weston | Feb 2015 | B2 |
9044579 | Blott et al. | Jun 2015 | B2 |
9050398 | Armstrong et al. | Jun 2015 | B2 |
9061095 | Adie et al. | Jun 2015 | B2 |
9180231 | Greener | Nov 2015 | B2 |
9204801 | Locke et al. | Dec 2015 | B2 |
9220822 | Hartwell | Dec 2015 | B2 |
9339248 | Tout et al. | May 2016 | B2 |
9408755 | Larsson | Aug 2016 | B2 |
9421132 | Dunn | Aug 2016 | B2 |
9655807 | Locke et al. | May 2017 | B2 |
9737649 | Begin et al. | Aug 2017 | B2 |
9757500 | Locke et al. | Sep 2017 | B2 |
9801986 | Greener | Oct 2017 | B2 |
9844472 | Hammond et al. | Dec 2017 | B2 |
9849023 | Hall et al. | Dec 2017 | B2 |
10117782 | Dagger et al. | Nov 2018 | B2 |
10537657 | Phillips et al. | Jan 2020 | B2 |
10660992 | Canner | May 2020 | B2 |
11357905 | Greener | Jun 2022 | B2 |
20010034499 | Sessions et al. | Oct 2001 | A1 |
20020022861 | Jacobs et al. | Feb 2002 | A1 |
20020077661 | Saadat | Jun 2002 | A1 |
20020161346 | Lockwood et al. | Oct 2002 | A1 |
20030114816 | Underhill et al. | Jun 2003 | A1 |
20030114818 | Benecke et al. | Jun 2003 | A1 |
20030114821 | Underhill et al. | Jun 2003 | A1 |
20030120249 | Wulz et al. | Jun 2003 | A1 |
20030121588 | Pargass et al. | Jul 2003 | A1 |
20030220660 | Kortenbach et al. | Nov 2003 | A1 |
20040010275 | Jacobs et al. | Jan 2004 | A1 |
20040054346 | Zhu et al. | Mar 2004 | A1 |
20040162512 | Liedtke et al. | Aug 2004 | A1 |
20040267312 | Kanner et al. | Dec 2004 | A1 |
20050107731 | Sessions | May 2005 | A1 |
20050119694 | Jacobs et al. | Jun 2005 | A1 |
20050142331 | Anderson et al. | Jun 2005 | A1 |
20050222613 | Ryan | Oct 2005 | A1 |
20050258887 | Ito et al. | Nov 2005 | A1 |
20050267424 | Eriksson et al. | Dec 2005 | A1 |
20060020269 | Cheng | Jan 2006 | A1 |
20060058842 | Wilke et al. | Mar 2006 | A1 |
20060064124 | Zhu et al. | Mar 2006 | A1 |
20060069357 | Marasco | Mar 2006 | A1 |
20060079599 | Arthur | Apr 2006 | A1 |
20060135921 | Wiercinski et al. | Jun 2006 | A1 |
20060155260 | Blott et al. | Jul 2006 | A1 |
20060213527 | Argenta et al. | Sep 2006 | A1 |
20060217795 | Besselink et al. | Sep 2006 | A1 |
20060257457 | Gorman et al. | Nov 2006 | A1 |
20060259074 | Kelleher et al. | Nov 2006 | A1 |
20060271018 | Korf | Nov 2006 | A1 |
20070032755 | Walsh | Feb 2007 | A1 |
20070052144 | Knirck et al. | Mar 2007 | A1 |
20070104941 | Kameda et al. | May 2007 | A1 |
20070118096 | Smith et al. | May 2007 | A1 |
20070123816 | Zhu et al. | May 2007 | A1 |
20070123973 | Roth et al. | May 2007 | A1 |
20070129660 | McLeod et al. | Jun 2007 | A1 |
20070149910 | Zocher | Jun 2007 | A1 |
20070179421 | Farrow | Aug 2007 | A1 |
20070185463 | Mulligan | Aug 2007 | A1 |
20070213597 | Wooster | Sep 2007 | A1 |
20070282309 | Bengtson et al. | Dec 2007 | A1 |
20070282374 | Sogard et al. | Dec 2007 | A1 |
20070299541 | Chernomorsky et al. | Dec 2007 | A1 |
20080041401 | Casola et al. | Feb 2008 | A1 |
20080108977 | Heaton et al. | May 2008 | A1 |
20080243096 | Svedman | Oct 2008 | A1 |
20080275409 | Kane et al. | Nov 2008 | A1 |
20080287973 | Aster et al. | Nov 2008 | A1 |
20080306456 | Riesinger | Dec 2008 | A1 |
20090005716 | Abuzaina et al. | Jan 2009 | A1 |
20090005744 | Karpowicz et al. | Jan 2009 | A1 |
20090043268 | Eddy et al. | Feb 2009 | A1 |
20090069760 | Finklestein | Mar 2009 | A1 |
20090069904 | Picha | Mar 2009 | A1 |
20090093550 | Rolfes et al. | Apr 2009 | A1 |
20090099519 | Kaplan | Apr 2009 | A1 |
20090105670 | Bentley et al. | Apr 2009 | A1 |
20090137973 | Karpowicz et al. | May 2009 | A1 |
20090204423 | Degheest et al. | Aug 2009 | A1 |
20090227938 | Fasching et al. | Sep 2009 | A1 |
20090246238 | Gorman et al. | Oct 2009 | A1 |
20090299303 | Seegert | Dec 2009 | A1 |
20090299307 | Barta | Dec 2009 | A1 |
20090299342 | Cavanaugh, II et al. | Dec 2009 | A1 |
20090312685 | Olsen et al. | Dec 2009 | A1 |
20100022990 | Karpowicz et al. | Jan 2010 | A1 |
20100028407 | Del Priore et al. | Feb 2010 | A1 |
20100030132 | Niezgoda et al. | Feb 2010 | A1 |
20100036333 | Schenk, III et al. | Feb 2010 | A1 |
20100047324 | Fritz et al. | Feb 2010 | A1 |
20100069863 | Olson | Mar 2010 | A1 |
20100081983 | Zocher et al. | Apr 2010 | A1 |
20100121287 | Smith et al. | May 2010 | A1 |
20100137775 | Hu et al. | Jun 2010 | A1 |
20100137890 | Martinez et al. | Jun 2010 | A1 |
20100150991 | Bernstein | Jun 2010 | A1 |
20100160874 | Robinson et al. | Jun 2010 | A1 |
20100179515 | Swain et al. | Jul 2010 | A1 |
20100198128 | Turnlund et al. | Aug 2010 | A1 |
20100211030 | Turner et al. | Aug 2010 | A1 |
20100256672 | Weinberg et al. | Oct 2010 | A1 |
20100262092 | Hartwell | Oct 2010 | A1 |
20100262126 | Hu et al. | Oct 2010 | A1 |
20100280468 | Haggstrom et al. | Nov 2010 | A1 |
20100292717 | Petter-Puchner et al. | Nov 2010 | A1 |
20100312159 | Aali et al. | Dec 2010 | A1 |
20110009838 | Greener | Jan 2011 | A1 |
20110021965 | Karp et al. | Jan 2011 | A1 |
20110022082 | Burke et al. | Jan 2011 | A1 |
20110059291 | Boyce et al. | Mar 2011 | A1 |
20110066096 | Svedman | Mar 2011 | A1 |
20110077605 | Karpowicz et al. | Mar 2011 | A1 |
20110082480 | Viola | Apr 2011 | A1 |
20110106026 | Wu et al. | May 2011 | A1 |
20110110996 | Schoenberger et al. | May 2011 | A1 |
20110112458 | Holm et al. | May 2011 | A1 |
20110130774 | Criscuolo et al. | Jun 2011 | A1 |
20110178451 | Robinson et al. | Jul 2011 | A1 |
20110213319 | Blott et al. | Sep 2011 | A1 |
20110224631 | Simmons et al. | Sep 2011 | A1 |
20110224632 | Zimnitsky et al. | Sep 2011 | A1 |
20110224634 | Locke et al. | Sep 2011 | A1 |
20110238095 | Browning | Sep 2011 | A1 |
20110264138 | Avelar et al. | Oct 2011 | A1 |
20110282136 | Browning | Nov 2011 | A1 |
20110282310 | Boehringer et al. | Nov 2011 | A1 |
20110305736 | Wieland et al. | Dec 2011 | A1 |
20120004631 | Hartwell | Jan 2012 | A9 |
20120010637 | Stopek et al. | Jan 2012 | A1 |
20120016321 | Wu et al. | Jan 2012 | A1 |
20120029449 | Khosrowshahi | Feb 2012 | A1 |
20120029455 | Perez-Foullerat et al. | Feb 2012 | A1 |
20120035560 | Eddy et al. | Feb 2012 | A1 |
20120041402 | Greener | Feb 2012 | A1 |
20120059399 | Hoke et al. | Mar 2012 | A1 |
20120059412 | Fleischmann | Mar 2012 | A1 |
20120071841 | Bengtson | Mar 2012 | A1 |
20120109188 | Viola | May 2012 | A1 |
20120121556 | Fraser et al. | May 2012 | A1 |
20120130327 | Marquez Canada | May 2012 | A1 |
20120136326 | Croizat et al. | May 2012 | A1 |
20120136328 | Johannison et al. | May 2012 | A1 |
20120143113 | Robinson et al. | Jun 2012 | A1 |
20120144989 | Du Plessis et al. | Jun 2012 | A1 |
20120150133 | Heaton et al. | Jun 2012 | A1 |
20120165764 | Allen et al. | Jun 2012 | A1 |
20120172926 | Hotter | Jul 2012 | A1 |
20120191054 | Kazala, Jr. et al. | Jul 2012 | A1 |
20120191132 | Sargeant | Jul 2012 | A1 |
20120197415 | Montanari et al. | Aug 2012 | A1 |
20120209226 | Simmons et al. | Aug 2012 | A1 |
20120209227 | Dunn | Aug 2012 | A1 |
20120238931 | Rastegar et al. | Sep 2012 | A1 |
20120253302 | Corley | Oct 2012 | A1 |
20120277773 | Sargeant et al. | Nov 2012 | A1 |
20130012891 | Gross et al. | Jan 2013 | A1 |
20130023842 | Song | Jan 2013 | A1 |
20130066365 | Belson et al. | Mar 2013 | A1 |
20130096518 | Hall et al. | Apr 2013 | A1 |
20130110058 | Adie et al. | May 2013 | A1 |
20130110066 | Sharma et al. | May 2013 | A1 |
20130150813 | Gordon et al. | Jun 2013 | A1 |
20130150814 | Buan | Jun 2013 | A1 |
20130190705 | Vess et al. | Jul 2013 | A1 |
20130197457 | Kazala, Jr. et al. | Aug 2013 | A1 |
20130204213 | Heagle et al. | Aug 2013 | A1 |
20130245527 | Croizat et al. | Sep 2013 | A1 |
20130253401 | Locke et al. | Sep 2013 | A1 |
20130325142 | Hunter et al. | Dec 2013 | A1 |
20130331757 | Belson | Dec 2013 | A1 |
20140068914 | Coward et al. | Mar 2014 | A1 |
20140094730 | Greener et al. | Apr 2014 | A1 |
20140109560 | Ilievski et al. | Apr 2014 | A1 |
20140163415 | Zaiken et al. | Jun 2014 | A1 |
20140180229 | Fuller et al. | Jun 2014 | A1 |
20140195004 | Engqvist et al. | Jul 2014 | A9 |
20140249495 | Mumby et al. | Sep 2014 | A1 |
20140316359 | Collinson et al. | Oct 2014 | A1 |
20140343518 | Riesinger | Nov 2014 | A1 |
20150025484 | Simmons et al. | Jan 2015 | A1 |
20150065968 | Sealy et al. | Mar 2015 | A1 |
20150119837 | Thompson, Jr. et al. | Apr 2015 | A1 |
20150148760 | Dodd et al. | May 2015 | A1 |
20150157758 | Blücher et al. | Jun 2015 | A1 |
20150159066 | Hartwell et al. | Jun 2015 | A1 |
20150174304 | Askem et al. | Jun 2015 | A1 |
20150190288 | Dunn et al. | Jul 2015 | A1 |
20150196431 | Dunn et al. | Jul 2015 | A1 |
20160166744 | Hartwell et al. | Jun 2016 | A1 |
20170065751 | Toth | Mar 2017 | A1 |
20170156611 | Burnett et al. | Jun 2017 | A1 |
Number | Date | Country |
---|---|---|
2012261793 | Nov 2014 | AU |
2013206230 | May 2016 | AU |
1438904 | Aug 2003 | CN |
101112326 | Jan 2008 | CN |
101123930 | Feb 2008 | CN |
101588836 | Nov 2009 | CN |
101744688 | Jun 2010 | CN |
201519362 | Jul 2010 | CN |
102038575 | May 2011 | CN |
102196830 | Sep 2011 | CN |
102256637 | Nov 2011 | CN |
102781380 | Nov 2012 | CN |
202568632 | Dec 2012 | CN |
103071197 | May 2013 | CN |
2949920 | Mar 1981 | DE |
1320342 | Jun 2003 | EP |
2279016 | Feb 2011 | EP |
2366721 | Sep 2011 | EP |
2368523 | Sep 2011 | EP |
2404626 | Jan 2012 | EP |
2341955 | Dec 2012 | EP |
2547375 | Jan 2013 | EP |
2567682 | Mar 2013 | EP |
2567717 | Mar 2013 | EP |
2594299 | May 2013 | EP |
2601984 | Jun 2013 | EP |
2623137 | Aug 2013 | EP |
2367517 | Sep 2013 | EP |
3225261 | Oct 2017 | EP |
2389794 | Dec 2003 | GB |
2378392 | Jun 2004 | GB |
2423019 | Aug 2006 | GB |
2489947 | Oct 2012 | GB |
2496310 | May 2013 | GB |
S6257560 | Mar 1987 | JP |
2006528038 | Dec 2006 | JP |
2007505678 | Mar 2007 | JP |
2008529618 | Aug 2008 | JP |
2009525087 | Jul 2009 | JP |
2009536851 | Oct 2009 | JP |
2011523575 | Aug 2011 | JP |
2012105840 | Jun 2012 | JP |
62504 | Apr 2007 | RU |
1818103 | May 1993 | SU |
WO-0185248 | Nov 2001 | WO |
WO-0189392 | Nov 2001 | WO |
WO-0205737 | Jan 2002 | WO |
WO-03003948 | Jan 2003 | WO |
WO-03049598 | Jun 2003 | WO |
WO-2004018020 | Mar 2004 | WO |
WO-2004037334 | May 2004 | WO |
WO-2005046761 | May 2005 | WO |
WO-2005105174 | Nov 2005 | WO |
WO-2006041496 | Apr 2006 | WO |
WO-2006046060 | May 2006 | WO |
WO-2007030601 | Mar 2007 | WO |
WO-2007133618 | Nov 2007 | WO |
WO-2008027449 | Mar 2008 | WO |
WO-2008039223 | Apr 2008 | WO |
WO-2008064502 | Jun 2008 | WO |
WO-2008091521 | Jul 2008 | WO |
WO-2008104609 | Sep 2008 | WO |
WO-2009019495 | Feb 2009 | WO |
WO-2009071926 | Jun 2009 | WO |
WO-2009071933 | Jun 2009 | WO |
WO-2009112062 | Sep 2009 | WO |
WO-2009112848 | Sep 2009 | WO |
WO-2009114624 | Sep 2009 | WO |
WO-2009156709 | Dec 2009 | WO |
WO-2009158132 | Dec 2009 | WO |
WO-2010033725 | Mar 2010 | WO |
WO-2010051073 | May 2010 | WO |
WO-2010059612 | May 2010 | WO |
WO-2010075180 | Jul 2010 | WO |
WO-2010078349 | Jul 2010 | WO |
WO-2010092334 | Aug 2010 | WO |
WO-2010097570 | Sep 2010 | WO |
WO-2011023384 | Mar 2011 | WO |
WO-2011087871 | Jul 2011 | WO |
WO-2011091169 | Jul 2011 | WO |
WO-2011106722 | Sep 2011 | WO |
WO-2011135284 | Nov 2011 | WO |
WO-2011135286 | Nov 2011 | WO |
WO-2011135287 | Nov 2011 | WO |
WO-2011137230 | Nov 2011 | WO |
WO-2011144888 | Nov 2011 | WO |
WO-2012021553 | Feb 2012 | WO |
WO-2012038727 | Mar 2012 | WO |
WO-2012069793 | May 2012 | WO |
WO-2012082716 | Jun 2012 | WO |
WO-2012082876 | Jun 2012 | WO |
WO-2012112204 | Aug 2012 | WO |
WO-2012136707 | Oct 2012 | WO |
WO-2012142473 | Oct 2012 | WO |
WO-2012156655 | Nov 2012 | WO |
WO-2012168678 | Dec 2012 | WO |
WO-2013007973 | Jan 2013 | WO |
WO-2013012381 | Jan 2013 | WO |
WO-2013043258 | Mar 2013 | WO |
WO-2013071243 | May 2013 | WO |
WO-2013079947 | Jun 2013 | WO |
WO-2013175309 | Nov 2013 | WO |
WO-2013175310 | Nov 2013 | WO |
WO-2014013348 | Jan 2014 | WO |
WO-2014014842 | Jan 2014 | WO |
WO-2014014871 | Jan 2014 | WO |
WO-2014014922 | Jan 2014 | WO |
WO-2014024048 | Feb 2014 | WO |
WO-2014140578 | Sep 2014 | WO |
WO-2014158526 | Oct 2014 | WO |
WO-2014165275 | Oct 2014 | WO |
WO-2014178945 | Nov 2014 | WO |
Entry |
---|
International Preliminary Report on Patentability for Application No. PCT/IB2013/002485, dated Nov. 25, 2014, 8 pages. |
International Search Report and Written Opinion for Application No. PCT/IB2013/002485, dated Apr. 23, 2014, 12 pages. |
Kapischke M., et al., “Self-Fixating Mesh for the Lichtenstein Procedure-a Prestudy,” Langenbecks Arch Surg, 2010, vol. 395, pp. 317-322. |
Number | Date | Country | |
---|---|---|---|
20200352790 A1 | Nov 2020 | US |
Number | Date | Country | |
---|---|---|---|
61784304 | Mar 2013 | US | |
61681037 | Aug 2012 | US | |
61651483 | May 2012 | US | |
61650391 | May 2012 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15837948 | Dec 2017 | US |
Child | 16885127 | US | |
Parent | 14402674 | US | |
Child | 15837948 | US |